Oramed Pharmaceuticals Inc. · NASDAQ:ORMP

Gabay Avraham sold 20,000 Oramed Pharmaceuticals Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Gabay Avraham (Chief Financial Officer) sold 20,000 Oramed Pharmaceuticals Inc. shares at US$4.51 for US$90,200 under a trading plan, leaving 861,076 shares. Filed Oct 2, 2026 (Form 4).

Sold
20,000 shares
Price
US$4.51
Value
US$90,200
Holding after
861,076 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockSale20,000US$4.51861,076Direct

Source

View original at SEC

Related